Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PANTOPRAZOLE Cause Interstitial lung disease? 317 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 317 reports of Interstitial lung disease have been filed in association with PANTOPRAZOLE (Pantoprazole Sodium). This represents 0.4% of all adverse event reports for PANTOPRAZOLE.

317
Reports of Interstitial lung disease with PANTOPRAZOLE
0.4%
of all PANTOPRAZOLE reports
53
Deaths
199
Hospitalizations

How Dangerous Is Interstitial lung disease From PANTOPRAZOLE?

Of the 317 reports, 53 (16.7%) resulted in death, 199 (62.8%) required hospitalization, and 33 (10.4%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE. However, 317 reports have been filed with the FAERS database.

What Other Side Effects Does PANTOPRAZOLE Cause?

Chronic kidney disease (28,127) Acute kidney injury (15,961) Renal failure (11,543) End stage renal disease (8,523) Renal injury (7,070) Drug ineffective (5,487) Off label use (4,279) Pain (4,057) Dyspnoea (4,052) Fatigue (3,797)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which PANTOPRAZOLE Alternatives Have Lower Interstitial lung disease Risk?

PANTOPRAZOLE vs PANTOPRAZOLE ANHYDROUS PANTOPRAZOLE vs PANTOTHENIC ACID PANTOPRAZOLE vs PAPAVERINE PANTOPRAZOLE vs PARACETAMOL PANTOPRAZOLE vs PARATHYROID HORMONE

Related Pages

PANTOPRAZOLE Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease PANTOPRAZOLE Demographics